These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33074297)

  • 1. Pregnancy and Fetal Outcomes Following Exposure to Modafinil and Armodafinil During Pregnancy.
    Kaplan S; Braverman DL; Frishman I; Bartov N
    JAMA Intern Med; 2021 Feb; 181(2):275-277. PubMed ID: 33074297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stevens-Johnson Syndrome After Armodafinil Use.
    Holfinger S; Roy A; Schmidt M
    J Clin Sleep Med; 2018 May; 14(5):885-887. PubMed ID: 29734973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens-Johnson syndrome induced by modafinil.
    Prince V; Philippidou M; Walsh S; Creamer D
    Clin Exp Dermatol; 2018 Mar; 43(2):191-192. PubMed ID: 29028129
    [No Abstract]   [Full Text] [Related]  

  • 4. First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations.
    Damkier P; Broe A
    JAMA; 2020 Jan; 323(4):374-376. PubMed ID: 31990303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Malformations After Early Pregnancy Exposure to Modafinil in Sweden and Norway.
    Cesta CE; Engeland A; Karlsson P; Kieler H; Reutfors J; Furu K
    JAMA; 2020 Sep; 324(9):895-897. PubMed ID: 32870289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hypertensive crisis and severe headache after concurrent use of armodafinil and tranylcypromine: Case report and review of the literature.
    Kinslow CJ; Shapiro SD; Grunebaum MF; Miller EC
    J Neurol Sci; 2018 Oct; 393():1-3. PubMed ID: 30077942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.
    Dauvilliers Y; Bassetti C; Lammers GJ; Arnulf I; Mayer G; Rodenbeck A; Lehert P; Ding CL; Lecomte JM; Schwartz JC;
    Lancet Neurol; 2013 Nov; 12(11):1068-75. PubMed ID: 24107292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modafinil and the risk of cardiovascular events: Findings from three US claims databases.
    Kaplan S; Goehring EL; Melamed-Gal S; Nguyen-Khoa BA; Knebel H; Jones JK
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1182-1190. PubMed ID: 30106194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials.
    Kuan YC; Wu D; Huang KW; Chi NF; Hu CJ; Chung CC; Tam KW; Huang YH
    Clin Ther; 2016 Apr; 38(4):874-88. PubMed ID: 26923035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infant Exposure to Armodafinil Through Human Milk Following Maternal Use of Modafinil.
    Leggett C; Ritchie U; Costi L; Elliot D; Mangoni AA; Hague WM
    J Hum Lact; 2023 May; 39(2):218-222. PubMed ID: 36384330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the potential for a pharmacokinetic drug-drug interaction between armodafinil and ziprasidone in healthy adults.
    Darwish M; Bond M; Yang R; Hellriegel ET; Robertson P
    Clin Drug Investig; 2014 Oct; 34(10):691-9. PubMed ID: 25047407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Armodafinil for excessive daytime sleepiness.
    Nishino S; Okuro M
    Drugs Today (Barc); 2008 Jun; 44(6):395-414. PubMed ID: 18596995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A need for new treatments in narcolepsy.
    Strambi LF
    Lancet Neurol; 2013 Nov; 12(11):1039-40. PubMed ID: 24107291
    [No Abstract]   [Full Text] [Related]  

  • 15. Armodafinil.
    Garnock-Jones KP; Dhillon S; Scott LJ
    CNS Drugs; 2009 Sep; 23(9):793-803. PubMed ID: 19689169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
    Black JE; Hull SG; Tiller J; Yang R; Harsh JR
    J Clin Sleep Med; 2010 Oct; 6(5):458-66. PubMed ID: 20957846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis.
    Chapman JL; Vakulin A; Hedner J; Yee BJ; Marshall NS
    Eur Respir J; 2016 May; 47(5):1420-8. PubMed ID: 26846828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study.
    Darwish M; Kirby M; Hellriegel ET; Yang R; Robertson P
    Drugs Aging; 2011 Feb; 28(2):139-50. PubMed ID: 21275439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil Reduces Parasympathetic Activity but Does Not Influence Autonomic Reactivity to Orthostatic Load in Narcolepsy Type 1.
    Bušek P; Bušková J; Miletínová E; Mladá K; Nevšímalová S; Šonka K
    Clin Neuropharmacol; 2018; 41(4):111-115. PubMed ID: 29901476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
    Schwartz JR; Khan A; McCall WV; Weintraub J; Tiller J
    J Clin Sleep Med; 2010 Oct; 6(5):450-7. PubMed ID: 20957845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.